Racial profiling in medical research

New England Journal of Medicine

Volumn 344, Issue 18, 2001, Pages 1392-1393

  Schwartz, R S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

DRUG EFFICACY; EDITORIAL; HEART FAILURE; HEART VENTRICLE FUNCTION; HEREDITY; HUMAN; MEDICAL RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIAL ASPECT;

BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL APPROACH/SOURCE;

CONTINENTAL POPULATION GROUPS; GENOME, HUMAN; HUMANS; MUTATION; RESEARCH; SOCIOLOGY;

EID: 0035799778     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200105033441810     Document Type: Editorial

References (13)

1. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure
2. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction
3. AAA statement on race
4. For 7 million people in census, one race category isn't enough
5. The medicalization of race: Scientific legitimization of a flawed social construct
6. The sequence of the human genome
7. Determinants of diabetes mellitus in the Pima Indians
8. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans
9. The genetics of breast cancer susceptibility
10. Initial sequencing and analysis of the human genome
11. Racial differences in the response to drugs - Pointers to genetic differences
12. Census, race and science